Shares in Spanish biotech company Oryzon Genomics plunged 30 percent on Thursday after Swiss drugmaker Roche pulled out of a deal to develop its... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/0lYrkcVX_y4/us-oryzon-roche-idINKBN1A50SZ
ZURICH (Reuters) - A run of disappointing drug trials at Roche has left analysts suggesting the view from its new 41-storey office building in... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/KBtv-qegXvI/us-roche-growth-idINKBN1A410Y
(Updates) ** Generic drugmaker's shares up about 2 pct at$39.80 in light premarket trading ** Advisory committee to FDA unanimously recommends... ...http://www.sify.com/finance/buzz-fda-panel-okays-mylan-biocons-copy-of-roches-herceptin-news-others-rhosEqaahfajj.html
Posted by Equitymaster Indian share markets continue to trade near the dotted line during the noon session. Pharma stocks and bank stocks witnessed... ...http://www.equitymaster.com/tm/tm.asp?date=7/14/2017&title=Sensex-Down-37-Points-Infosys-Up-on-Q1-Results
4 2017 01:07:14 PM Daijiworld Media Network – Mangaluru (EP) Mangaluru, Jul 14: The seventh death anniversary and sixth year's memorial Konkani... ...http://www.daijiworld.com/news/newsDisplay.aspx?newsID=461397
Roche is a Emerging company as a IVR...